<DOC>
	<DOC>NCT00510172</DOC>
	<brief_summary>We hypothesised that intravenous infusion of PGI2 induced headache or migraine and cranial vasodilatation in migraineurs.</brief_summary>
	<brief_title>Migraine Inducing Effects and Changes in Brain Haemodynamics of PGI2</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Epoprostenol</mesh_term>
	<mesh_term>Tezosentan</mesh_term>
	<criteria>migraine without aura and healthy apart from that age 1855 years 50100 kg Secure contraceptives Tension Type Headache more than 3 time a month Other primary headaches Medication prior to the study (closer than 4 times plasma halflife) Migraine or headache 5 days prior to study. Hypertension (systolic BP &gt;150 mmHg and/or diastolic BP &gt;100 mmHg). Hypotension (systolic BP &lt;90 mmHg and/or diastolic BP &lt;50 mmHg). Heartvessel disease of any kind incl cerebrovascular disease. Anamnestic or clinical signs of psychiatric disease or abuse. Anamnestic or clinical signs of disease of any kind relevant for participation in the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Headache</keyword>
	<keyword>Migraine</keyword>
	<keyword>Vasodilatation</keyword>
</DOC>